CYP2A6 and the plasma level of 5-chloro-2, 4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1.
Cancer Sci
; 99(5): 1049-54, 2008 May.
Article
in En
| MEDLINE
| ID: mdl-18380793
Full text:
1
Database:
MEDLINE
Main subject:
Oxonic Acid
/
Pyridines
/
Aryl Hydrocarbon Hydroxylases
/
Tegafur
/
Fluorouracil
/
Mixed Function Oxygenases
/
Antimetabolites, Antineoplastic
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2008
Type:
Article